SciMar ONE is a pharmaceutical technology (pharma-tech) company dedicated to transforming the way pharmaceutical companies launch and commercialize therapies.  With over two decades of experience spanning commercial, clinical, and medical roles, our team has seen firsthand how operational inefficiencies derail even the most promising therapies.

The Problem We Set Out to Solve

The story is common: spend 7 to 10 years and hundreds of millions of dollars developing a drug—only to miss financial expectations. It happens to one in three drugs.

The problem is not the science—it’s the execution. According to Deloitte, the root cause is lack of launch readiness: cross-functional teams start too late, work in silos, and rely on manual, disconnected processes. The result is an inadequate understanding of the market, poor product differentiation, and minimal market access— a lost commercial opportunity.

At SciMar ONE, we have lived this problem—and we built the solution.